- Using AI to detect retinopathy in prematurity.
Envision adds ChatGPT to its smart glasses.
- New drug demonstrates efficacy for RP patients.
- Medicare deficiencies causing preventable blindness.
- And, about 15 more stories about the science and medicine related to blindness from the entire world.
World Blind herald does not write the stories to which we link in Science Briefs, we gather them, curate them and bring them to our readers. We are not scientists ourselves and cannot guarantee the validity of the stories in this digest. We do, however, want to be very clear that you should not attempt any of the medical interventions mentioned in Science Briefs without first consulting a professional ophthalmologist and discussing it with them. Do not take medical advice from this or any other web site or podcast without first consulting a professional.
Blind Girl Designs
Blind Girl Designs, fun and unique apparel for you!
We have creative, delightful, white cane inspired prints on T-shirts, sweatshirts and hoodies.
We also carry dresses and cardigans size Small-XXL.
Call us at 862-448-1011, for an audio description or to place an order. Visit our website.
Science and Medicine
Thousands of blind people are missing out on NHS services that are essential for helping them with everyday tasks such as cooking and reading. This story comes to us from: The Daily Mail.
An international team of scientists led by UCL and Moorfields Eye Hospital … cause of childhood blindness in middle income countries and the US. This story comes to us from: Association of Optometrists.
Cataracts are a leading cause of global blindness affecting half of the world's visually impaired population. This story comes to us from: Scoop NZ.
Blindness can onset at any point in life. The World Health Organisation has calculated that at least 2.2 billion people worldwide have a visual impairment, with at least 1 billion of these not being addressed. This story comes to us from: Palatinate.
a leading developer of smart glasses that can help blind people read and identify objects, has now incorporated a game-changing voice-activated sight assistant into its glasses powered by the most advanced artificial intelligence ever built. This story comes to us from: Forbes.
The scientists are optimistic that this technology will greatly enhance the quality of life for those suffering from depression. This story comes to us from: News18.
[Summer Mudford's cruel disease: Diagnosed with dementia at eight years old102]
The Cambridge, New Zealand school girl has a rare, incurable form of Batten disease, which causes blindness, childhood dementia and loss of mobility. This story comes to us from: The NZ Herald.
In a presentation at the Association for Research in Vision and Ophthalmology annual meeting in New Orleans, Kiora Pharmaceuticals showed its investigational drug has the potential to restore light perception in patients who are blind or living with ultra-low vision due to retinitis pigmentosa. This story comes to us from: Ophthalmology Times.
Our purpose was to evaluate visual acuity in aniridia subjects and the more severely affected phenotype in WAGR syndrome subjects, and to assess. This story comes to us: Dove Medical Press.
While milder forms of ROP do not require treatment, only monitoring, more acute cases require prompt treatment. This story comes to us from: Ophthalmology Times.
ATSN-201 leverages AAV capsid that spreads laterally beyond subretinal injection site to facilitate safe delivery of RS1 to photoreceptors in the central retina/fovea. This story comes to us from: BioSpace.
The study of epidemiological data on cataracts in China has significant implications for guiding blindness prevention and treatment efforts. This story comes to us from: Dove Medical Press.
MDFA patron and media icon Ita Buttrose told ACM treatment needed to be more affordable and accessible for ageing Australians. This story comes to us from: St George & Sutherland Shire Leader.
Insights from this study can help direct the creation of effective pharmaceutical treatments for myopia. This story comes to us from: Physician's Weekly.
Australian researchers have identified the role that two key genes associated with age-related macular degeneration (AMD) play in the disease. The team, led by CERA's principal investigator of cellular reprogramming, Associate Professor Raymond Wong, have for the first time found that the genes TMEM97 and POLDIP2 play a role in regulating oxidative stress—a part of aging in the macula. This story comes to us from: Medical Xpress.